Biginelli reaction
Biginelli Reaction
The Biginelli reaction is a significant chemical reaction that allows for the synthesis of dihydropyrimidinones (DHPMs), which are a class of heterocyclic compounds. This reaction was first reported in 1893 by Pietro Biginelli, an Italian chemist, hence its name. The Biginelli reaction is a multicomponent reaction (MCR), meaning it involves the simultaneous reaction of three or more starting materials to form a product, where the core structure is a 3,4-dihydropyrimidin-2(1H)-one. The typical substrates for this reaction include an aldehyde, a β-keto ester (or a β-diketone), and urea or thiourea.
Reaction Mechanism[edit | edit source]
The mechanism of the Biginelli reaction involves several steps, starting with the formation of an enamine from the β-keto ester and the aldehyde. This enamine then reacts with urea or thiourea to form an intermediate, which undergoes cyclization to produce the dihydropyrimidinone core structure. The reaction is typically acid-catalyzed, with various acids being used to promote the reaction, including both organic and inorganic acids.
Variations and Developments[edit | edit source]
Over the years, several modifications and improvements have been made to the original Biginelli reaction protocol to increase its efficiency, yield, and scope. These include the use of different catalysts, such as Lewis acids, Brønsted acids, and even heterogeneous catalysts. Additionally, microwave-assisted and solvent-free conditions have been explored to enhance the reaction rates and environmental friendliness of the process.
Applications[edit | edit source]
Dihydropyrimidinones, the products of the Biginelli reaction, exhibit a wide range of biological activities, including antihypertensive, antiviral, and anticancer properties. This makes the Biginelli reaction an important tool in medicinal chemistry for the synthesis of new pharmaceuticals. Furthermore, the reaction is used in the synthesis of calcium channel blockers, a class of medications used to treat high blood pressure.
See Also[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD